Infections and Biological Therapy in Patients with Rheumatic Diseases

被引：0

作者：

Atzeni, Fabiola ^{[1
]}

Batticciotto, Alberto ^{[2
]}

Masala, Ignazio F. ^{[3
]}

Talotta, Rossella ^{[2
]}

Benucci, Maurizio ^{[4
]}

Sarzi-Puttini, Piercarlo ^{[2
]}

机构：

[1] IRCCS Galeazzi Orthoped Inst, Milan, Italy

[2] L Sacco Univ Hosp, Rheumatol Unit, GB Grassi 74, I-20127 Milan, Italy

[3] Santissima Trinita Hosp, Orthoped & Trauma Unit, Cagliari, Italy

[4] S Giovanni Dio Hosp, Rheumatol Unit, Florence, Italy

来源：

ISRAEL MEDICAL ASSOCIATION JOURNAL | 2016年 / 18卷 / 3-4期

关键词：

anti-tumor necrosis factor (TNF) drugs; newer biological drugs; fungal and viral infections; anti-CD20; anti-interleukin; 6; ANTI-TNF THERAPY; NECROSIS FACTOR THERAPY; HEPATITIS-B; SERIOUS INFECTIONS; BRITISH-SOCIETY; VIRUS-INFECTION; INCREASED RISK; ARTHRITIS; TUBERCULOSIS; REACTIVATION;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Long-term extension studies and observational drug registers have revealed an increased risk of serious infections in patients treated with anti-tumor necrosis factor agents, particularly infliximab, etanercept and adalimumab. The same may be true for the newer biological drugs rituximab, tocilizumab and abatacept, although this has yet to be confirmed by long-term observational studies. We review the risk of tuberculosis, herpes zoster and other opportunistic infections, and the recommendations for screening for tuberculosis and hepatitis B and C infections in patients with rheumatoid arthritis, with the aim of informing patients and encouraging greater awareness among physicians.

引用

页码：164 / 167

页数：4

共 50 条

[1] INFECTIONS IN PATIENTS WITH RHEUMATIC DISEASES IN TREATMENT WITH BIOLOGIC THERAPY
Teran, V. Rivera
Vega-Morales, D.
Sicsik, S.
Irazoque-Palazuelos, F.
Saavedra, M. A.
Casasola, J. C.
Carrilo, S.
Pena, A.
Ortiz, A. Castillo
Munoz-Monroy, O. E.
Barragan, S. Duran
Ramos, A.
Corona, L. F. Valdes
Valdez, E. Torres
Paz, A.
Zamora-Tehozol, E. A.
Torres, A.
Mendieta, S.
Friedmann, D. X. Xibille
Guerrero, F.
Santana, N.
Vazquez, M.
Zepeda, C.
Rivera, M.
Alvarado, K.
Alpizar-Rodriguezon, D.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1824 - 1824
[2] Biological therapy in rheumatic diseases
Mas, A. Juan
[J]. MEDICINA BALEAR, 2008, 23 (03): : 11 - 16
[3] Biological therapy for the treatment of rheumatic diseases
Pierer, M.
Baerwald, C.
[J]. INTERNIST, 2008, 49 (08): : 938 - 946
[4] Infections and treatment of patients with rheumatic diseases
Atzeni, Fabiola
Bendtzen, Klaus
Bobbio-Pallavicini, Francesca
Conti, Fabrizio
Cutolo, Maurizio
Montecucco, Carloinaurizio
Sulli, Alberto
Valesini, Guido
Sarzi-Puttini, Piercarlo
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (01) : S67 - S73
[5] Frequent Infections in Patients with Inflammatory Rheumatic Diseases
Ehrenstein, B.
[J]. AKTUELLE RHEUMATOLOGIE, 2014, 39 (03) : 170 - 174
[6] Infections after Biologic Agent Therapy in rheumatic diseases
Kinikli, S.
Kinikli, G.
Kucuksahin, O.
Turgay, M.
Ates, A.
[J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 348 - 349
[7] Screening for Leishmania specific antibodies among patients with rheumatic diseases treated with biological therapy
Szabados, Fruzsina
Nielsen, Henrik Vedel
Fuursted, Kurt
Linauskas, Asta
Rasmussen, Claus
Leutscher, Peter Derek Christian
[J]. EUROPEAN JOURNAL OF RHEUMATOLOGY, 2022, 9 (02) : 114 - 115
[8] OVERLOOKING SEVERE INFECTIONS DURING TOCILIZUMAB THERAPY FOR THE RHEUMATIC DISEASES
Kikuchi, E.
Suzuki, A.
Uekubo, K.
Aoki, N.
Yoshioka, T.
Ishiyama, Y.
Okai, T.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 880 - 881
[9] Infections in Patients with Rheumatic Diseases Treated with TNF Antagonists
Perez-Zafrilla, Beatriz
Carmona, Loreto
Gomez-Reino, Juan J.
[J]. CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2012, 13 (08) : 1418 - 1425
[10] Satisfaction and Adherence to Biological Treatment in Patients with Rheumatic Diseases
Hammad, Marwa
Bakry, Huny
[J]. CURRENT RHEUMATOLOGY REVIEWS, 2022, 18 (03) : 250 - 256

← 1 2 3 4 5 →